Preveceutical Medical

Preveceutical Medical EBITDA per Share

EBITDA per Share of Preveceutical Medical (PREV.CN) as of Nov 13, 2026.

EBITDA per Share

-0.00CAD

YoY

14.37%

Last updated:

EBITDA per Share of Preveceutical Medical is 2022 -0.00 CAD. EBITDA per Share of Preveceutical Medical was 2021 -0.00 CAD. It decreases by 14.37% lower compared to the previous year.

The Preveceutical Medical EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2016
-0.06 CAD
Jan 1, 2017
-0.10 CAD
Jan 1, 2018
-0.02 CAD
Jan 1, 2019
-0.01 CAD
Jan 1, 2020
-0.00 CAD
Jan 1, 2021
-0.00 CAD
Jan 1, 2022
-0.00 CAD
The Preveceutical Medical EBITDA per Share history
YEAREBITDA per ShareYoY
-0.00CAD+14.37%
-0.00CAD-61.21%
-0.00CAD-46.19%
-0.01CAD-61.03%
-0.02CAD-78.38%
-0.10CAD+65.45%
-0.06CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Preveceutical Medical Stock analysis

What does Preveceutical Medical do? Preveceutical Medical Inc, based in Vancouver, Canada, specializes in licensing, branding, and marketing nutraceutical and wellness products. The company, listed on 30 December 2016, focuses on developing preventive and curative therapies using organic and nature-identical products. Its pipeline includes a cannabinoid-based nose-to-brain delivery system for pain and neurological conditions, a non-addictive analgesic peptide for pain management, a BSV peptide program targeting cancer, and dual gene therapy for type 2 diabetes and obesity. The company operates through its subsidiary in Australia for research management. Preveceutical Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Preveceutical Medical stock

On Eulerpool you can find the complete historical development of EBITDA per Share Preveceutical Medical since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Preveceutical Medical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Preveceutical Medical